In situ sprayed hydrogels containing resiquimod-loaded liposomes reduce chronic osteomyelitis recurrence by intracellular bacteria clearance
Open Access
- 27 July 2023
- journal article
- research article
- Published by Elsevier in Acta Biomaterialia
- Vol. 169, 209-227
Abstract
No abstract availableKeywords
Funding Information
- Guangzhou Municipal Science and Technology Program key projects
- Southern Medical University (202002020001, 2020A0505100039, 2022E02040)
- Science and Technology Planning Project of Guangdong Province
This publication has 49 references indexed in Scilit:
- Nanoparticle-assisted ultrasound: A special focus on sonodynamic therapy against cancerChemical Engineering Journal, 2018
- Biocompatibility, biodegradation and excretion of polylactic acid (PLA) in medical implants and theranostic systemsChemical Engineering Journal, 2018
- Staphylococcus aureus biofilm elicits the expansion, activation and polarization of myeloid-derived suppressor cells in vivo and in vitroPLOS ONE, 2017
- Systemic autoimmunity induced by the TLR7/8 agonist Resiquimod causes myocarditis and dilated cardiomyopathy in a new mouse model of autoimmune heart diseaseDisease Models & Mechanisms, 2017
- Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and β-thalassemiaProceedings of the National Academy of Sciences, 2016
- Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trialThe Lancet, 2015
- OsteomyelitisThe Lancet, 2004
- Osteomyelitis Debridement TechniquesClinical Orthopaedics and Related Research, 1999
- OsteomyelitisNew England Journal of Medicine, 1997
- Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implantsAntimicrobial Agents and Chemotherapy, 1993